The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

Researchers believe they have developed the first dedicated blood test to diagnose chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), which has the potential to be a ...

Roche's Elecsys pTau181 test is the second blood-based biomarker test to receive FDA clearance for Alzheimer’s disease this year. - Sarah Silbiger/Getty Images The US Food and Drug Administration has ...

FDA cleared the Elecsys pTau181 test as the first blood-based biomarker to aid in the initial assessment of Alzheimer's disease and other causes of cognitive decline that can be used in the primary ...

Oct 13 (Reuters) - Roche Diagnostics (ROG.S), opens new tab said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's (LLY.N), opens new tab blood test as an aid in the ...

FILE PHOTO: FILE PHOTO: The Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo (Reuters) -Roche Diagnostics said ...

The U.S. Food and Drug Administration has cleared another blood test that could help doctors identify whether a patient's memory problems are likely caused by Alzheimer's disease. The new test, called ...